Roche Vs Natco: Supreme Court clears decks for launch of Natco Pharma’s Risdiplam generic in India
[ad_1] The Supreme Court on Friday cleared decks for Natco Pharma to launch its generic version of the drug Risdiplam in India, even as it dismissed Swiss drugmaker F. Hoffmann-La Roche’s appeal seeking to restrain the Hyderbad firm. Risdiplam is an oral medicine used for spinal muscular atrophy (SMA) in patients two months or older…